Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04224909
Other study ID # 0633-19-TLV
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date February 1, 2020
Est. completion date January 31, 2021

Study information

Verified date January 2020
Source Tel-Aviv Sourasky Medical Center
Contact Yahav Oron, MD
Phone 036973573
Email yahavo@tlvmc.gov.il
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The function of the vestibular system among patients with Sudden Sensori Neural Hearing Loss will be evaluted using the video Head Impulse Test


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date January 31, 2021
Est. primary completion date January 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients hospitalized with the diagnosis of Sudden Sensorineural Hearing Loss

Exclusion Criteria:

- Vertigo

- Other etiology causing dizziness

- Neurological dysfunction othe than the hearing loss

- Difficulty performing the vHIT

- Chronic vestibular disorder

- Pregnant women

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Video Head Impulse Test
Diagnosis of dysfunction of the semicircular canals using the vHIT

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Tel-Aviv Sourasky Medical Center

Outcome

Type Measure Description Time frame Safety issue
Primary The gain of each canal, as calculated using the vHIT Gain measured by the vHIT system 15 minutes
See also
  Status Clinical Trial Phase
Completed NCT04120116 - FX-322 in Adults With Stable Sensorineural Hearing Loss Phase 2
Recruiting NCT05403229 - The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss Phase 2
Not yet recruiting NCT05608161 - Speech Perception Impairment Follow Complete Recovery of Sudden Sensorineural Hearing Loss
Recruiting NCT04961099 - Phase I Clinical Study of HY01 in Patients Phase 1
Recruiting NCT06278129 - Evaluation of the Diagnostic and Prognostic Efficacy of MRI in Acute Sensorineural Hearing Loss and Ménière's Disease
Recruiting NCT06249919 - A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients Phase 1/Phase 2
Recruiting NCT04826237 - Oral Statins and Protection From Hearing Loss Phase 4
Recruiting NCT05849519 - Small Sample,Unicentric,Randomized, Controlled Clinical Study of Coenzyme I for Injection in the Treatment of Sudden Sensorineural Hearing Loss Early Phase 1
Not yet recruiting NCT06365775 - Multi-omics Characteristics and Prognosis of Idiopathic Sudden Sensorineural Hearing Loss
Not yet recruiting NCT06355102 - The Development of Tinnitus in Patients With SSNHL: Insights From fMRI and Metabolomics